Microfluidic Devices Market in the Healthcare Industry to 2015

2013-01-22
Published : Jan-2013

TechNavio”s analysts forecast the Global Microfluidic Devices market in the Healthcare industry to grow at a CAGR of 26.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing use of microfluidic devices in proteomics and genomics. The Global Microfluidic Devices market in the Healthcare industry has also been witnessing the trend of the increasing use of microfluidic devices in drug discovery. However, the intense competition among vendors could pose a challenge to the growth of this market.

TechNavio”s report, the Global Microfluidic Devices Market in the Healthcare Industry 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Monoclonal Antibodies market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Fluidigm Corp., RainDance Technologies Inc., Agilent Technologies Inc., and Dolomite Centre Ltd.

The other vendors mentioned in the report are Micronit Microfluidics BV, Illumina Inc., MicruX Technologies Inc., Abbott Laboratories, Boehringer Ingelheim GmbH, BioFluidix GmbH, Abaxis Inc., Advion Biosciences Inc., Caliper Life Sciences Inc., Cepheid Inc., Danaher Corp., Eksigent Technologies Inc., GE Novasensor Inc., Illumina Inc., Johnson and Johnson, Konica Minolta Holdings Inc., Microfluidic Systems Inc., Life Technologies Corp., Philips Healthcare, Roche Diagnostics, Shimadzu Biotech, and Siemens Healthcare.

Key questions answered in this report:
What will the market size be in 2015 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.

TechNavio”s research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.

Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=212064.

Table of Contents

01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Product Offerings
04. Market Landscape
Market Size and Forecast
04.1 Market Segmentation by Application
04.2 Five Forces Analysis
05. Vendor Landscape
06. Buying Criteria
07. Market Growth Drivers
08. Drivers and Their Impact
09. Market Challenges
10. Impact of Drivers and Challenges
11. Market Trends
12. Key Vendor Analysis
12.1 Fluidigm Corp.
Business Overview
Key Information
SWOT Analysis
12.2 RainDance Technologies Inc.
Business Overview
Key Information
SWOT Analysis
12.3 Agilent Technologies Inc.
Business Overview
Key Information
SWOT Analysis
12.4 Dolomite Centre Ltd.
Business Overview
Key Information
SWOT Analysis
13. Other Reports in this Series

List of Exhibits:
Exhibit 1: Global Microfluidic Devices Market in the Healthcare Industry 2011-2015 (US$ million)
Exhibit 2: Global Microfluidic Devices Market in the Healthcare Industry Segmentation by Application 2011
Exhibit 3: Global Microfluidic Devices Market in the Healthcare Industry Segmentation 2011-2015 (in percent)
Exhibit 4: Global Microfluidic Devices Market in the Healthcare Industry Segmentation 2011-2015 (in US$ million)
Exhibit 5: Global Microfluidic Devices Market in the Healthcare Industry by Vendor Segmentation (by revenue) 2011

Contact sales@reportsandreports.com for further information.

Filed in: Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

Global Foot Insoles Market 2017-2021

Due to its structural nature, the human foot is intended to walk on natural grounds and without the use of high heels. The unusual inclined position of the foot due to heels and often flat floor will result in damage to the foot and therefore, in the podalgia. Most humans are born with healthy feet. Damage to the feet predominantly develops with time. The causes are disposition, overweight, hard grounds, wrong footwear, sport injuries, rheumatic changes, circulatory disorders, and neuropathies. The analysts forecast global foot insoles market to grow at a CAGR of 6.64% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global foot insoles market for 2017-2021. To calculate the market size, the report considers......
$3500

Global Cancer Monoclonal Antibodies Market 2017-2021

The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from other targeted therapeutics. The analysts forecast the global cancer monoclonal antibodies market to grow at a CAGR of 10.86% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global cancer monoclonal antibodies market for 2017-2021. To calculate the market size, This report considers the revenue generated from the sales of branded cancer mAbs and biosimilars used to treat cancer. It also considers the revenues to be......
$3500

Global Multiple Myeloma Drugs Market 2017-2021

Multiple myeloma is an abnormal growth and accumulation of plasma cells in the bone marrow leading to malignancy. This can be caused by the overproduction of monoclonal immunoglobulins such as IgG, IgA, IgD, or IgE; or Bence-Jones protein. Under normal conditions, stem cells develop into B lymphocytes, mature in the lymph nodes, and are transported throughout the body. On the entry of foreign substances into the body, these B-cells develop into plasma cells and produce immunoglobulins against the disease. However, in multiple myeloma, the B-cells are damaged and give rise to many malignant plasma cells that produce excessive immunoglobulins of a single type, which the body does not require. The analysts forecast the global multiple myeloma drugs market to grow at a CAGR of 9.19% during ......
$3500

Global Smart Healthcare Market 2016-2020

Smart healthcare is the integration of different healthcare delivery mechanisms. It makes use of electronic patient records and streamlining processes, which leads to improved quality of life by reducing the risks to health (by remote monitoring and checks) and improving the general well-being of people. Smart healthcare provides more patient-centric services that improves access to healthcare and are customized to individual patients' needs. The analysts forecast global smart healthcare market to grow at a CAGR of 24.55% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global smart healthcare market for 2016-2020. To calculate the market size, the report considers the revenue generated from solutions EHR, ......
$2500

Nurse Call System Market in the US 2016-2020

The NCS helps a caregiver and a patient to effectively communicate with each other and enhance patient care. In the US, individuals undergoing treatment in specialized healthcare facilities such as in SNFs, ALFs, and ACFs need constant attention and care. Hence, to provide 24/7 care to them, there is a need for a dedicated line of communication between patients and caregivers; NCS are used for this purpose. The analysts forecast nurse call system market in the US to grow at a CAGR of 14.18% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the nurse call system market in the US for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of NCS, including nurse call comp......
$2500

Global Pompe Disease Treatment Market 2016-2020

Lysosomal storage diseases (LSDs) are a group of progressive, autosomal recessive, and hereditary disorders characterized by the accumulation of specific substrates and variable age of onset and clinical symptoms. Pompe disease, a type of LSD, is caused by mutations in the GAA gene. These mutations inhibit the mechanism of action (MOA) of GAA; it is an enzyme responsible for catabolizing glycogen, resulting in accumulation of glycogen to toxic levels in the lysosomes of the cells. The buildup of glycogen in certain tissues and organs, especially in the muscles, hinders the normal functions of the organs. It can be further divided as adult-onset and infantile-onset Pompe diseases. As the disease is an autosomal recessive hereditary disorder, both parents are carriers and pass one copy of th......
$2500

Global Human Respiratory Syncytial Virus Drugs Market 2016-2020

Respiratory syncytial virus (RSV) is a virus that leads to infections in the lungs and the respiratory tract. It commonly affects most children in the ages 2 or below. RSV can also infect adults. In adults and the older population, the symptoms of RSV are mild and similar to that of common cold. Infection with RSV can be severe in certain cases, particularly in premature infants and babies with underlying health conditions. RSV can also become serious in the older population or adults with heart and lung diseases, or any individual with a very weak immune system. The analysts forecast global human respiratory syncytial virus drugs market to grow at a CAGR of 4.27% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects o......
$2500

Global Cervical Cancer Diagnostic Testing Market 2016-2020

The global cervical cancer diagnostic testing market is growing steadily, primarily due to the availability and awareness of the programs in the developed countries. This test enables women aged 21 years and above to get screened, making most of the pre-cancerous lesions identifiable at stages when they can be treated easily. In the US, National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides low-cost even free cervical cancer screening for uninsured and low-income women. As per the Affordable Care Act, all health insurance plans initiated after September 23, 2010, should provide recommended cervical cancer screening tests to end-users. In developing countries, with the widespread awareness programs by public organizations like the WHO along with government initiative......
$2500

Global Active Pharmaceutical Ingredients Market 2017-2021

A drug is generally composed of APIs and excipients. Active Pharmaceutical Ingredients are chemical compounds or a combination of compounds that are used primarily to have the desired effect on biological systems. Excipients are inactive ingredients in a drug that are used to disperse APIs. APIs may be synthesized either through chemical or biotechnological methods. The analysts forecast global active pharmaceutical ingredients market to grow at a CAGR of 6.61% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global active pharmaceutical ingredients market for 2017-2021. To calculate the market size, the report considers the sales of APIs in key applications areas of the pharmaceutical industry. The report ......
$3500

Global M2M Healthcare Market 2016-2020

M2M healthcare is the collective term for telehealth, telecare, telemedicine, mobile health, digital health, and eHealth services. It is a model for healthcare delivery which uses technology to provide healthcare remotely. M2M creates smart communication environments such as connected healthcare. It is an emerging ecosystem of IP-connected devices with the potential to deliver significant business benefits valued at trillions of dollars in the future across varied industries. The analysts forecast global M2M healthcare market to grow at a CAGR of 43.52% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global M2M healthcare market for 2016-2020. To calculate the market size, the report considers the revenue ......
$2500